BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 232306)

  • 1. [Current aspects of recovery and invalidism in recurrent pulmonary tuberculosis].
    Grigorescu V; Petrescu M; Popescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1979; 28(4):247-53. PubMed ID: 232306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immediate results of strictly supervised, intermittent treatment with rifampicin and ethambutol in patients with chronic pulmonary tuberculosis].
    Josefovics F; Vojth B; Vojth V
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1977; 26(1):35-8. PubMed ID: 191889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Studies of resumption of treatment with rifampin and ethambutol in patients with recurrent pulmonary tuberculosis].
    Jozefovics F; Barbu Z; Bálinth E; Ovári AM
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1978; 27(3):177-84. PubMed ID: 212815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Results of a therapeutic trial comparing a 6-month regimen to a 12-month regimen in the treatment of pulmonary tuberculosis in the Algerian Sahara. Final report: results 3 years after the onset of treatment].
    Berkani M; Chaulet P; Darbyshire JH; Nunn A; Fox W
    Rev Mal Respir; 1986; 3(2):73-85. PubMed ID: 3726263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Organization, administration and results of strictly supervised treatment with rifampicin and ethambutol in a group of chronic tubercular patients in the Constanta area].
    Marinescu L; Panghea P; Didilescu C
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1974; 23(5):445-50. PubMed ID: 4377624
    [No Abstract]   [Full Text] [Related]  

  • 6. Supervised ambulatory treatment of tuberculosis with brief initial hospitalization.
    Riska H
    Scand J Respir Dis Suppl; 1973; 83():1-59. PubMed ID: 4127838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Long-term results of treatment with rifampicin and ethambutol in hyperchronic pulmonary tuberculosis with polyresistant bacilli].
    Anastasatu C; Sibila S
    Ftiziologia; 1973; 22(5):477-84. PubMed ID: 4751363
    [No Abstract]   [Full Text] [Related]  

  • 8. [Antitubercular therapeutic regimens routinely prescribed in Bas-Rhin and results of treatment].
    Liard R; Perdrizet S; Burghard G; Petitjean R; Rempp M; Pierau F; Chenuet J
    Rev Mal Respir; 1986; 3(2):93-7. PubMed ID: 3726265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factors influencing time to smear conversion in patients with smear-positive pulmonary tuberculosis.
    Wang JY; Lee LN; Yu CJ; Chien YJ; Yang PC;
    Respirology; 2009 Sep; 14(7):1012-9. PubMed ID: 19659516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectivity of intermittent RMP/EMB treatment in patients with chronic pulmonary tuberculosis (author's transl)].
    Frenzel I; Neumeyer D
    Z Erkr Atmungsorgane; 1976 Aug; 146(2):145-52. PubMed ID: 1020361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Reactivation of pulmonary tuberculosis in patients treated with rifampicin and ethambutol].
    Kuznetsova ZA
    Probl Tuberk; 1985; (12):40-2. PubMed ID: 4095097
    [No Abstract]   [Full Text] [Related]  

  • 12. [Cases of tuberculosis of the respiratory system in patients over 60].
    Didilescu C; Ciobanu M
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1985; 34(4):359-67. PubMed ID: 3012755
    [No Abstract]   [Full Text] [Related]  

  • 13. [Characteristics and treatment outcomes of INH-resistant or RFP-resistant tuberculosis].
    Saito W; Nagayama N; Miyamoto M; Hara H; Suzuki J; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2003 Oct; 78(10):611-7. PubMed ID: 14621568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of rifampicin and ethambutol on indices of the sympathoadrenal system in patients with recurrent pulmonary tuberculosis].
    Grozovskaia MS
    Probl Tuberk; 1985; (10):38-40. PubMed ID: 4070203
    [No Abstract]   [Full Text] [Related]  

  • 15. [Rifampicin combined with ethambutol and other antitubercular drugs in the treatment of patients with pulmonary tuberculosis. Early results. I. Bacteriological evaluation].
    Masztalerz J
    Pneumonol Pol; 1976; 44(1):55-60. PubMed ID: 821043
    [No Abstract]   [Full Text] [Related]  

  • 16. [Proceedings: The rate of recurrence in patients reported for pulmonary tuberculosis in the past 10 years].
    Ciocan A
    Ftiziologia; 1974; 23(1):39-44. PubMed ID: 4822459
    [No Abstract]   [Full Text] [Related]  

  • 17. Rifampicin--ethambutol in retreatment of pulmonary tuberculosis.
    Mital OP; Narang RK; Sachan AS
    Indian J Chest Dis Allied Sci; 1976 Jul; 18(3):141-5. PubMed ID: 1026643
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacteriologic results and relapses of sputum-positive reactions in 110 tuberculous patients treated with ethambutol].
    Szarewicz-Adamczyk W; Przemyska B; Mysakowska H; Grodzki S; Marciniak T
    Gruzlica; 1974 Mar; 42(3):221-7. PubMed ID: 4822090
    [No Abstract]   [Full Text] [Related]  

  • 19. [The reactivation of pulmonary tuberculosis after effective chemotherapy using rifampicin].
    Roslik SM; Pashkov IuN; Matveeva SL; Gerasimova TG; Liudvichek IA; Iushchenko LP; Iakovleva LM; Stepanenko AL; Pankova LI
    Vrach Delo; 1990 Nov; (11):18-20. PubMed ID: 2098972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics and outcome of tuberculosis patients whose sputum smears are positive at or after 5 months of treatment.
    Harries AD; Gausi F; Chimzizi R; Salaniponi FM
    Int J Tuberc Lung Dis; 2004 Mar; 8(3):384-7. PubMed ID: 15139479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.